Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Recent Scientific Development of HIV Vaccine and HIV Prevention Strategies"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 15 November 2023 | Viewed by 1070
Special Issue Editors
Interests: respiratory; HIV; HIV vaccines; tuberculosis
E-Mail Website1 Website2
Interests: immunology; nano-medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
The past few years have witnessed many promising advances in HIV prevention strategies involving preexposure prophylaxis approaches. Despite the tremendous efforts to develop a successful human immunodeficiency virus (HIV) vaccine, the quest for a safe and effective HIV vaccine seems to be remarkably long. An effective vaccine is needed to stop the continuing spread of HIV worldwide. A number of unique characteristics of the biology of HIV infections make the creation of an HIV vaccine particularly challenging. Together with other HIV prevention approaches, preventive and therapeutic HIV vaccines will be invaluable tools in bringing the epidemic to an end.
This Special Issue is open to any subject area related to “HIV Vaccine and HIV Prevention Strategies”. We invite research employing quantitative and qualitative methods as well as contributions featuring under-researched populations.
Dr. Jaykaran Charan
Dr. Nagesh Kolishetti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- HIV vaccine
- HIV prevention